Similar Articles
Evaluation of Demographic, Clinical Characteristics and Side Effects in Multiple Sclerosis Patients Vaccinated Against SARS-CoV-2 Virus
Özgü Kizek, Gizem Yağmur Yalçın, Tuncay Gündüz, Murat Kürtüncü, Mefküre Eraksoy
DOI: 10.4274/tnd.2022.97493
Sodium Valproate-induced Adult-onset Type 2 Citrullinemia
Başak Elçin Ateş, Turgay Demir, Deniz Kor, Remzi Emre Şahin, Şebnem Bıçakçı
DOI: 10.4274/tnd.2022.37539
Prognosis in Patients Who were Diagnosed as Having Stroke, Using Warfarin, and Aged Over Eighty Years: A Clinical Observation
R. Gökçen Gözübatık Çelik, Hayriye Küçükoğlu, Eda Çoban, Songül Şenadım, Ayhan Köksal
DOI: 10.4274/tnd.2019.53367
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale
DOI: 10.4274/tnd.2019.75725
Holmes’ Tremor due to Hemi-cerebellar Encephalomalacia and Improvement with Valproic Acid Therapy
Halil Önder
DOI: 10.4274/tnd.2018.84666
Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
Burcu Altunrende, Erkingül Birday, Mithat Kasap, Gülşen Akman Demir
DOI: 10.4274/tnd.62144
Applications of Botulinum Toxin at a Neurology Clinic: An Eleven-year Experience
Hasan Rifat Koyuncuoğlu, Seden Demirci
DOI: 10.4274/tnd.04809
Efficacy of Botulinum Toxin Injections in the Treatment of Various Types of Facial Region Disorders
Arzu Çoban, Zeliha Matur, Haşmet A. Hanağası, Yeşim Parman
DOI: 10.4274/Tnd.26097
Valproate-Induced Encephalopathy in Three Cases
Fatma Polat, Aslı Köşkderelioğlu, Sezin Alpaydın, Nesli Keskinöz, Nilgün Araç, Ali Saffet Gönül, Ayşe Kocaman, Hadiye Şirin
Ergotamine Tartrate in Migraine Attack and Tolerance Development
Hulusi Keçeci, Yıldız Değirmenci
Side Effects of Intravenous Immunoglobulin Treatment in Neurological Disorders
Buket Oflazoğlu, Fatma Öztürk, Hatice Kayaalp Açık, Çağatay Öncel, Ülker Anadol, Hulki Forta